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ABSTRACT
Introduction Antimicrobial resistance is a global 
challenge that threatens our ability to prevent and treat 
common infectious diseases. Vietnam is affected by high 
rates of antimicrobial resistant infections, driven by the 
overuse of antibiotics and the Vietnamese government 
has recognised antimicrobial resistance as a health 
security priority. This study aimed to understand how 
people in Vietnam use antibiotics in community settings, 
and the factors that impact their practices and decision- 
making regarding antibiotics.
Methods We conducted 43 qualitative in- depth 
interviews with 50 community members in two urban 
and two rural sites in Vietnam. We conducted iterative, 
inductive thematic analysis alongside data collection 
through a process of systematic debriefings based on 
detailed interview summaries. Through this process, we 
developed a coding framework that was then applied to 
transcribed interview data.
Results Frequent and indiscriminate use of antibiotics 
was driven by the powerful appeal that antibiotics held 
for many Vietnamese consumers. Consumers were 
discerning in making decisions in their purchase and 
use of antibiotics. Consumers’ decisions were affected 
by perceptions of what constitutes high- quality medicine 
(effective, strong, accessible and affordable); privileging 
symptom control over diagnosis; social constructions of 
antibiotics as a trusted remedy with embodied evidence 
of prior efficacy, which is reinforced by advice from 
trusted sources in their community; and varied, generally 
incomplete, understanding of the concept of antibiotic 
resistance and its implications for individuals and for 
public health.
Conclusion Antibiotic use at the community and 
primary care level in Vietnam is driven by community 
members’ social and economic response to what 
constitutes effective healthcare, rather than biomedical 
logic. Community- based interventions to reduce 
unnecessary antibiotic use need to engage with the 
entangled socio- structural factors that ‘resist’ current 
public health efforts to ration antibiotic use, alongside 
biomedical drivers. This study has informed the design 
of a community- based trial to reduce unnecessary 
antibiotic use.
INTRODUCTION
Antimicrobial resistance (AMR) is a global 
challenge that threatens our ability to treat 
common infectious diseases with antimi-
crobials. Drug- resistant disease causes over 
700 000 deaths worldwide per year,1 and is 
a considerable economic burden to health 
Key questions
What is already known?
 ► Antimicrobial resistance is a global public health 
threat.
 ► Vietnam is affected by high rates of antimicrobial 
resistant disease, partly driven by unnecessary an-
tibiotic use.
 ► Approaches to reducing antibiotic use that focus 
on individual behaviour change have been largely 
unsuccessful in reducing unnecessary antibiotic 
consumption.
What are the new findings?
 ► Vietnamese consumers’ decisions were affected by 
community perceptions of what constitutes high- 
quality medicine; privileging symptom control over 
diagnosis; social constructions of antibiotics as a 
trusted remedy; and limited understanding of the 
concept of antibiotic resistance.
 ► Social networks play an important role in influencing 
and reinforcing consumers’ purchase and consump-
tion of antibiotics.
 ► The risks of antimicrobial resistance have been in-
terpreted by community members as the risk of the 
individual being harmed by antibiotics, or becoming 
immune to antibiotics, rather than being understood 
as a risk to the community as a whole.
What do the new findings imply?
 ► Community- based interventions to reduce unneces-
sary antibiotic use need to engage with community 
values and structural conditions that drive antibiotic 
use, alongside biomedical drivers.
 ► Rather than simply discouraging antibiotic use, in-
terventions should promote alternatives that provide 
similar perceived benefits as antibiotics.
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systems.1–4 Within 30 years, AMR is predicted to be among 
the leading causes of mortality globally, disproportion-
ately impacting populations in low/middle- income coun-
tries (LMICs).5
Vietnam is already experiencing high rates of antimi-
crobial resistant disease. Overuse of antimicrobials, of 
which antibiotics are a subset, is one of several factors 
(including poor quality medications, inadequate AMR 
surveillance, poor community awareness, inadequate 
regulation, excessive agricultural use and economic 
drivers) linked to rising rates of antimicrobial resistant 
infections in Vietnam.6 7 At the hospital level, approxi-
mately one- third of antibiotics used annually in Vietnam 
are thought to be taken unnecessarily,8 and this propor-
tion is likely to be even higher at the community and 
primary care level, facilitated through private pharmacies 
and informal sellers servicing local markets.8
The Vietnamese health system has four levels: central, 
provincial, district and commune, with primary health 
services accessible to most of the population at the 
commune and district levels. However, there is an unoffi-
cial ‘fifth level’, with private pharmacies and drug outlets 
often used as the first point of primary care.9 10 This could 
be due to a range of factors, including their convenient 
opening hours, availability of common medicines, the 
ability to purchase medicines in small quantities, their 
geographical accessibility11 and their abundance. In 
2015, there were an estimated 66 registered drug outlets 
per 100 000 population in Vietnam; this figure does not 
include the significant number of unregistered drug 
outlets. The number of pharmacists is considerably lower, 
at 33.9 pharmacists per 100 000 population,12 indicating 
that many outlets are manned by staff with minimal 
formal pharmacy training.
Unregulated sales of prescription medication are 
driven by high perceived, and actual, consumer 
demand for antibiotics.10 13 Despite laws necessitating 
the use of prescriptions,14 antibiotics are widely sold 
without prescription at private pharmacies and drug 
stores.10 13 While the proportion of antibiotics sold 
without a prescription may be falling (estimations 
range from 88% to 91% in 201013 compared with 58% 
in 201815), non- prescription purchases still constitute 
the majority of antibiotic purchases from pharmacies.15 
In previous studies, the majority of non- prescription 
purchases were for customers with symptoms of respi-
ratory tract infections (cough, runny nose, sore throat) 
that are frequently viral,15 and fever. The antibiotics most 
commonly purchased over the counter were extended- 
spectrum penicillins such as amoxicillin and ampicillin, 
and first- generation cephalosporins, such as cepha-
lexin.13 15 In one study, around 40% of customers were 
provided with antibiotics classified by the WHO as antibi-
otics with higher resistance potential.15
The Vietnamese government has recognised AMR as a 
health security priority.16 However, to date, regulations to 
address inappropriate use and provision of antimicrobials 
have had limited impact. There is limited enforcement of 
legislation in practice,6 13 15 as well as limited provisions 
in place for dealing with the consequences of enforcing 
such regulations, such as increased pressure on the 
public health system and economic losses to business 
owners.10 Interventions to reduce inappropriate use of 
antimicrobial have focused on hospital- level stewardship 
programmes, with little attention paid to mediating the 
large amount of antibiotics consumed at the community 
level.15
It has often been assumed that overprescribing and 
overdispensing of antimicrobials in LMICs is due to 
limited knowledge about AMR and antimicrobial use 
among prescribers and dispensers.17 However, evidence 
from LMICs demonstrates that while awareness of 
AMR is often high, awareness does not lead to reduced 
prescribing or dispensing of antimicrobials.18 Among 
pharmacy employees in Vietnam, knowledge of antibi-
otics and AMR is mixed. Previous studies show a wide 
gap between knowledge and practice of pharmacists.19–21 
Among Vietnamese communities, knowledge of antibi-
otics and awareness of AMR have also been shown to be 
low, particularly in rural areas.13 22
While the problem of AMR is increasingly being 
recognised as requiring intersectoral (eg, agriculture, 
environment, health) and systemic interventions at 
national and regional levels, efforts to address consump-
tion tend to be focused on the level of the individual.23 24 
Approaches to reducing antibiotic use often focus on 
awareness raising, education and individual behaviour 
change (eg, changing prescribing practices), in an effort 
to improve knowledge which is assumed will lead to 
altered practices. However, recent research has shown 
that this focus on increasing knowledge and changing the 
behaviours of individuals has been largely unsuccessful in 
changing patterns of antibiotic consumption. Interven-
tions which focus on behaviour change and individual 
responsibility and emphasise the biomedically appro-
priate use of antibiotics, while neglecting the powerful 
socio- structural drivers of antibiotic use, are inadequate 
to address the factors shaping the sale, demand and 
consumption of antibiotics.23 25–28 Denyer Willis and 
Chandler argue that antibiotics function as a ‘quick fix’ 
for modern societies, conceptualising antibiotics, particu-
larly in LMICs, as infrastructure that supports, or corrects 
for, weak systems of care, productivity and hygiene.25 To 
date, interventions to tackle AMR rarely engage with 
addressing substantial systemic weaknesses to engender 
necessary long- term changes in practice, focusing instead 
on the immediacy of individual behaviour change, 
which may be superficial and unsustainable: privileging 
short- term, measurable success at the expense of more 
complex, long- term structural solutions.25 Similarly, 
Broom et al26 discuss the temporal myopia of modern life, 
a structural barrier which prevents the consideration of 
the long- term outcome of antimicrobial security in the 
face of the immediate demands of treating infection and 
achieving a positive patient outcome.
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Current research therefore indicates that interventions 
which are premised on providing accurate information 
that antibiotics are not appropriate to treat a range of 
viral infections will be insufficient to interrupt unneces-
sary antibiotic use. Instead, there needs to be a focus on 
the drivers of use within communities, which attends to 
the local context of consumption, and extends beyond 
presuming that biomedical logic is a primary concern in 
shaping or changing individuals’ engagement in antibi-
otic use. This study aimed to understand how people in 
Vietnam use antibiotics, and the factors that impact their 
practices and decision- making around antibiotics. The 
findings and key recommendations of this qualitative 
study have been used to inform the design of community 
interventions (including health promotion materials, 
resources for pharmacists and communication strategies) 
to reduce unnecessary antibiotic use within the primary 
care level of the health system. These interventions are to 
be implemented in a community- based trial, the start of 
which is currently postponed due to COVID-19.
METHODS
Study design
This study is underpinned by an interpretivist theoret-
ical perspective, a broad epistemological approach that 
is concerned with how individuals subjectively interpret 
or construct their experiences in relation to subjective 
and socially constructed contexts. We used a qualitative 
design to capture how individuals understand, inter-
pret, and rationalise their own experiences with antibi-
otics, and the extent to which antibiotic use is shaped by 
multiple aspects of daily life.
Setting
We conducted interviews between April and September 
2019 in two sites (one rural, one urban) in the munic-
ipality of Hanoi in the north of Vietnam, and two sites 
(one rural, one urban) in Ca Mau Province in the south. 
Sites were chosen in order to capture potential regional 
and cultural differences as well as urban/rural variation 
in the data.
Recruitment and sampling
Any community members (defined as residing in Hanoi 
municipality or Ca Mau Province) aged 18 years and 
over were eligible to participate. Different recruitment 
strategies were used in Hanoi and Ca Mau, according to 
the administrative requirements of the respective local 
authorities. In Hanoi, staff from local health services 
identified eligible participants according to the criteria 
provided by research staff and facilitated introductions 
to potential participants. In Ca Mau, recruitment was 
initially facilitated by local health authorities. However, 
with permission from local authorities, most participants 
in Ca Mau (approximately 80%) were approached by 
the interviewer in the community and recruited directly. 
Three people who were approached declined to partici-
pate for personal reasons.
Participants who completed an interview received 
100 000 Vietnamese dong (approximately US$4.3) 
as compensation for their time. All participants were 
provided with written participant information state-
ments prior to the interview. This information was also 
explained verbally to participants prior to the interview. 
All participants provided written consent.
Initially, a convenience approach to sampling was 
adopted to access a wide range of people for maximum 
variation. As data collection progressed, a theoretical 
sampling approach was developed, underpinned by our 
emerging thematic framework, in order to recruit from 
specific demographic groups who were reported to be 
responsible for making medical decisions for their house-
holds, such as mothers of young children and elders.
Participant sample
Fifty community members participated in 43 interviews 
(table 1). While the majority of interviews were conducted 
one on one, on five occasions, participants were inter-
viewed in pairs and on one occasion as a trio (eg, married 
couples, sisters, parent and adult child). In each instance, 
the participants requested to be interviewed alongside a 
close relation for their convenience (eg, to save partici-
pants’ time if multiple family members were being inter-
viewed) or comfort (eg, if an older participant wished to 
have their adult child present because they usually helped 
them with their health issues present). While multiple 
participant interviews can present issues for privacy and 
informed consent in some circumstances, particularly if 
unexpected and/or sensitive topics come to light, early 
interviews did not demonstrate that discussions around 
practices and beliefs around antibiotics elicited sensi-
tive information, and the data obtained from multipar-
ticipant interviews were not notably different from data 
obtained in one- on- one interviews. Each participant was 
only interviewed once. Participant occupations included 
small business owners, street vendors, motorbike taxi 
drivers, farmers, housewives/stay- at- home mothers, 
manufacturing workers, retired people and war veterans. 
Self- employment and informal sector work was common 
in both rural and urban study sites. In rural areas, this 
tended to be work related to agriculture and primary 
industries; in urban areas informal sector work was mostly 
related to small retail businesses and transport.
Data collection
In- depth interviews were conducted by local Vietnamese 
research staff (two women, one men) employed by the 
Woolcock Institute of Medical Research (DTH, TTT) and 
the National Institute of Hygiene Epidemiology (PTLN). 
All interviewers had previous experience conducting 
qualitative interviews and received further training from 
senior researchers prior to data collection, as well as 
ongoing support and supervision throughout the study. 
Interviewers did not have established relationships with 
participants prior to study commencement. Interviews 
were conducted in participants’ homes, workplaces, 
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and other venues convenient to the participants such as 
coffee shops and health facilities.
Interviewers used a flexible topic guide covering 
key areas of investigation (box 1). The topic guide 
was continuously refined throughout the data collec-
tion period, as part of the iterative analysis process 
whereby initial analyses based on systematic debriefing 
discussions29 informed ongoing sample selection and 
areas of inquiry. Interviews lasted from 30 to 100 min, 
with a median length of 60 min. Interviews were audio 
recorded and transcribed in Vietnamese. Transcriptions 
were then translated to English. Detailed summaries, 
based on listening to the audio recordings and supple-
mented by fieldnotes, were written up as soon as was 
feasible, usually within 1 or 2 days of the interview. Tran-
scripts were not returned to participants for checking. 
Data collection continued until thematic saturation 
was reached (ie, new data had become broadly repet-
itive of previously collected data in regard to the key 
themes),30 31 which was determined through regular 
analytical meetings throughout the data collection 
period.
Data analysis
We conducted iterative, inductive (data- driven) thematic 
analysis alongside data collection.32 33 Detailed written 
summaries formed the basis of systematic debriefing 
discussions (SM, DD, SB, DTH, TTT, PTLN) which were 
held via video call after every two to four interviews. 
These analytical discussions guided the identification of 
emerging themes and new areas of inquiry, as well as the 
recognition of saturation.29
Based on these extensive systematic debriefings and the 
detailed written interview summaries, SM developed the 
initial thematic coding framework. DTH, TTT and PTLN 
then each purposively selected a subset of transcripts to 
apply the coding framework, to check the comprehen-
siveness of the framework. Twenty- one transcripts were 
selected in order to achieve a broad variation of data 
within each subset. Analytical discussions were held 
regularly to update the coding framework and facilitate 
constant comparison across the team to ensure consis-
tency. All transcripts were then coded in Microsoft Word, 
using the comment function. Coded and summarised 
data were organised and charted using Google Sheets, 
taking note of alternative perspectives and outliers and 
adding additional illustrative quotes to the spreadsheet 
of coded and summarised data. Themes were then devel-
oped by looking at relationships between codes and data 
extracts, before being reviewed, refined and discussed 
with all authors.32
Box 1 Interview topic guide
Key areas of investigation
 ► Approaches to healing and treatment.
 ► Experiences of using antimicrobials.
 ► Access to antimicrobials.
 ► Attitudes to and knowledge of antimicrobials.
 ► Circulation, assimilation and rejection of information about health, 
medicine and antimicrobials in the community.
 ► Trusted and influential sources of health information in the 
community.
 ► Future solutions to antimicrobial resistance.
Table 1 Participant characteristics
Characteristics
Northern region Southern region
Rural Urban Total (%) Rural Urban Total (%) Total
Gender
  Female 9 5 14 (28) 11 6 17 (34) 31 (62)
  Male 7 3 10 (20) 6 3 9 (18) 19 (38)
Age (range 25–90)
  25–34 3 1 4 (8) 1 2 3 (6) 7 (14)
  35–44 2 1 3 (6) 4 1 5 (10) 8 (16)
  45–54 5 1 6 (12) 1 2 3 (6) 9 (18)
  55–64 2 2 4 (8) 3 2 5 (10) 9 (18)
  65–74 0 3 3 (6) 7 2 9 (18) 12 (24)
  ≥75 4 0 4 (8) 1 1 2 (4) 6 (12)
Employment
  Formal sector 5 4 9 (18) 4 0 4 (8) 13 (26)
  Informal sector 4 1 5 (10) 6 5 11 (22) 16 (32)
  Unpaid/dependent 6 2 8 (16) 0 2 2 (4) 10 (20)
  Pension 1 1 2 (4) 7 2 9 (18) 11 (22)
Total 16 8 24 (48) 17 9 26 (52) 50 (100)
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Patient and public involvement
The public were not directly involved in designing or 
conducting this study. This study is a part of the larger 
V- RESIST Study (Combating the Emergence and 
Spread of Antimicrobial Resistant Infectious Diseases 
in Vietnam). The study established a stakeholder group 
which consists of a large- scale multidisciplinary collabo-
ration between the health sector, academia and national 
policymakers from across Vietnam. This group meets 
biannually to work collaboratively on the design and 
development of interventions around AMR.
Participants have not provided feedback on the find-
ings. Feedback to participants is being prepared through 
the community- based trial (including presentation 
of findings and how they have informed the design of 
intervention material and communication strategies 
to community stakeholders and elicitation of commu-
nity feedback on these); however, the trial has been 
delayed due to COVID-19- related restrictions on public 
gatherings.
RESULTS
We found that antibiotics were used in the community 
for a variety of conditions and symptoms that often do 
not require antibiotics, including viral upper respiratory 
tract infections, pain, cuts and abrasions. Within the qual-
itative study, we are unable to make a judgement as to 
whether their own use of antibiotics was clinically ‘appro-
priate’. However, participants reported that their deci-
sions to purchase and use antibiotics for these conditions 
were generally made independently, or as recommended 
by pharmacy staff, not in consultation with a qualified 
prescribing clinician. Our findings demonstrate that the 
decision to use antibiotics can be at least partly explained 
by community perceptions of what constitutes a high- 
quality medicine; privileging control of symptoms over 
receiving a diagnosis; and social constructions of antibi-
otics as a trusted remedy for a wide range of conditions. 
Some participants modified their use of antibiotics based 
on concerns about AMR. However, what AMR meant and 
how to effectively address it was widely misunderstood.
The appeal of antibiotics
Antibiotics were considered broadly synonymous with 
Western medicines, distinct from the oppositional cate-
gory of ‘traditional’ medicines, and constituted a large 
proportion of Western medicines used by community 
members. Their appeal and credence were based on 
their perceived ‘Western’ origin, rather than on being 
antibiotics per se. Specifically, their appeal was predicated 
on their reputation for strength and their credibility 
was conferred by the tabular form and that they could 
be purchased in biomedical pharmacies. Antibiotics 
were emblematic of this broader category of ‘Western’ 
medicines, which were considered to indicate efficacy, 
strength, accessibility and affordability.
When I’m sick, I have to buy antibiotics. When I’m seri-
ously sick, antibiotics will cure my sickness. (28 years old, 
female, rural, Hanoi)
Efficacy and strength were demonstrated through 
perceived rapid relief of symptoms, which allowed people 
to experience minimal disruption to their daily activities. 
It is important to note that many conditions for which 
Vietnamese people use antibiotics are self- limiting, and 
people are frequently provided with supplementary 
over- the- counter medication when they buy antibiotics. 
Improvements that may be due to the passage of time 
or non- antimicrobial over- the- counter medication are 
therefore attributed to antibiotics.
Community members commonly gave a time frame 
of 2–3 days as the expected time to recover from illness 
if using ‘Western’ medications, with one participant 
likening the rapidity of effect to ‘instant noodles’ (51 
years old, male, urban, Ca Mau).
With Western medicines, people only need three days to 
recover and come back to work. (31 years old, female, ru-
ral, Hanoi)
Participants consistently characterised antibiotics as 
being inherently powerful, strong medications. Having 
partially absorbed messaging around the need for 
rationing such powerful medications, including poten-
tially through a series of national AMR public health 
campaigns, many participants were concerned about 
antibiotics’ potential for harm, even when using recom-
mended regimens.
I don’t take that medication too much because it has many 
harms. I don’t know. People said that antibiotics make you 
feel tired. (81 years old, male, rural, Hanoi)
It was common for participants to discuss self- regulating 
their dosage and course of antibiotics, in order to limit 
exposure to potential toxicity and harm. However, 
rationing of antibiotics did not often translate to more 
targeted, less frequent use. Not taking medication ‘too 
much’ in the above quote refers to self- prescribing short, 
rather than infrequent, courses.
Some participants specifically mentioned this harm- 
reduction approach to antibiotics in regard to their 
children, reflecting an underlying belief that balancing 
the strength and the potential toxicity of antibiotics was 
considered more risky for children. However, this was not 
a consistently found view, with other participants stating 
that their children required stronger medicine, as previ-
ously used medications had lost their effectiveness over 
time.
Antibiotics as affordable, efficient healthcare
Antibiotics were reported to be affordable and easily 
accessible. Despite regulations to the contrary, partici-
pants reported that it was common to purchase antibi-
otics over the counter at pharmacies and drug stores. 
Drug outlets are extremely common in the study area, 
with related research work showing that there were 133 
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and 81.7 outlets per 100 000 people in Hanoi munici-
pality and Ca Mau Province, respectively (Beardsley et al 
2021. Unpublished).
Pharmacies are all over the place. I can buy them at any 
store I want. It’s convenient, your only job is to decide 
whether or not to buy them at this store. (66 years old, 
male, rural, Ca Mau)
Consumers exercised discretion regarding the quantity 
of medicines they bought, with single doses readily avail-
able, and frequently purchased by participants.
Participants reported that antibiotics reduced the 
cost of healthcare. The unit cost of tablets was mostly 
described as inexpensive but, more broadly, purchasing 
them was considered to be a cheap and convenient way to 
access what they considered to be effective and efficient 
healthcare. Participants even described purchasing anti-
biotics pre- emptively on a contingency basis:
No doctor’s permission [prescription] needed. (…) Peo-
ple here often go to [Name]’s pharmacy and tell him to sell 
two ampi [ampicillin] tablets, and two tetra [tetracycline] 
tablets, just in case. (68 years old, female, rural, Ca Mau)
A minority of participants living with significant finan-
cial constraints said that while the cost of antibiotics 
was one of the factors that shaped their behaviour, the 
per unit cost was minor in comparison with the costs of 
engaging with the primary healthcare system, which was 
perceived to be cumbersome, time- consuming, burden-
some and potentially unsatisfactory. Pursuing a prescrip-
tion through a consultation with a doctor was presumed 
to either produce the same result (the purchase of 
antibiotics) or potentially curtailed access to antibiotics 
by the enforcement of circumspect prescribing prac-
tices. Circumventing the primary healthcare system by 
purchasing antibiotics directly from willing pharmacists 
not only reduced direct costs of healthcare, but also the 
indirect costs that accompanied engaging in primary 
healthcare, which would involve taking time off work and 
the delayed alleviation of symptoms.
I myself know that I should go to the doctor when I’m ill 
but going to the doctor means trading time for work…
It’s a dilemma. (…) If I go to the doctor this morning, I 
won’t have money for food this morning, meaning that my 
children won’t have anything to eat (…) I have to find the 
quickest solution to the problem (…) I choose to go to the 
pharmacy to buy Western medicines because it’s quicker… 
(44 years old, female, urban, Ca Mau)
Many participants, in both rural and urban sites, were 
precariously employed without access to sick leave. 
Paying for antibiotics offset other larger costs related to 
ill health, including lost income, both for the patient and 
often for an accompanying family member, and the finan-
cial and opportunity costs of engaging with primary care, 
including travel costs and inconvenience. These oppor-
tunity costs had the potential to be larger in rural areas, 
where there were few local alternatives to the commune- 
level health facility. In contrast, urban participants rarely 
engaged with commune health facilities, choosing instead 
to access higher level public services, or private practi-
tioners. Participants in rural areas would often travel long 
distances to reach their preferred higher level facility, if 
they perceived that the better quality of care provided 
would be worth the effort. But this effort was best saved 
for serious symptoms or specialist services. That antibi-
otics were considered to best meet their needs when they 
experienced more minor symptoms of illness reflects how 
the appeal of antibiotics is entangled with the structural 
inaccessibility of the primary healthcare system.
Symptom alleviation prioritised over diagnosis
Knowledge about whether a specific medicine was an 
appropriate treatment or not mattered less than its 
perceived ability to ‘cure’ (ie, alleviate symptoms) the 
problem quickly. While participants frequently self- 
prescribed antibiotics, self- diagnosis of a condition related 
to their symptoms was less common. There was minimal 
priority given to diagnosing the cause of illness if symp-
toms were not considered alarming but commonplace; 
instead they focused on the management and ameliora-
tion of symptoms. When recalling clinical consultations, 
while health professionals may have offered them diag-
noses, many participants did not remember them.
I only need him to dispense medicines for me, so I didn't 
ask why I had that condition. Maybe he wrote it on the pa-
per he gave me. But he didn't ask me many questions. In 
general doctors don’t ask many questions. (56 years old, 
female, rural, Ca Mau)
Many participants perceived there to be little qualita-
tive difference between visiting a pharmacy and buying 
antibiotics over the counter and consulting a clinician 
to receive a prescription. While participants trusted the 
clinical expertise of health professionals, their practical 
engagement with such expertise often privileged phar-
maceutical expertise which endorsed their own trust in 
specific medications and served to further justify their 
confidence in self- prescribing, without the need for it 
to be endorsed by a clinician who might offer an expert 
diagnosis of their condition. In an illustration of this, 
participants often mentioned that the credibility of health 
professionals and drug sellers rested on their ability to 
prescribe and dispense what the consumer considered 
to be ‘good medicines’ that alleviate symptoms quickly, 
rather than being wholly dependent on formal qualifica-
tions. A notable exception to this arose when a child was 
sick. The benefits of consulting a clinician were better 
appreciated in the context of childhood illness.
There is a seller in this area who has no medical training, 
but she can dispense very good medicines, people come 
to her a lot. Other younger pharmacists around here can-
not compete with her. They are all losing [business] to her, 
she just practices with her own experience in dispensing 
drugs, she’s very good, very fast. That lady is popular, her 
medicines take effect very quickly and that makes people 
recommend her. (66 years old, male, rural, Ca Mau)
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Social production of antibiotics as trusted
People’s trust in antibiotics was affirmed through 
witnessed (direct or indirect) and embodied evidence 
of that medicine having worked on previous occasions. 
Participants’ personal experience guided decisions 
about future treatments. If an antibiotic was perceived 
to have been effective for a relatively similar symptom 
or illness in the past, this evidence was presumed to be 
sufficient to justify its repeat purchase, ordinarily without 
it being considered necessary to check this with a qual-
ified prescriber. What constituted embodied evidence 
need not be personal. It could be passed on from close 
relatives, observed within social networks, or affirmed 
through anecdotal evidence from other trusted sources 
such as health professionals, and also community 
members without any formal medical training or quali-
fications.
In the past, my father used to buy it [ampicillin] for me to 
treat headache, flu, coughing. So, when I have a headache, 
flu, coughing, runny nose, I’ll buy it. (40 years old, female, 
rural, Ca Mau)
Informal circulation of health- related information 
within social networks played an important role in knowl-
edge transfer, particularly in rural areas. These interac-
tions often occurred in locations which are considered 
community hubs, such as markets, and social occasions 
such as parties.
Sometimes when we get together we all talk about health 
(…) we report back to each other who does their job well 
and [make] recommendations to each other. We discuss it 
in this neighbourhood. When our children and grandchil-
dren get sick, they will comment on each health facility, 
and others listen. (68 years old, female, rural, Ca Mau)
The reliance on embodied evidence was critical to 
positioning antibiotics as a trusted emblem of quality 
healthcare, which was known to be easily accessible. This 
operated in a reinforcing cycle: participants purchased 
antibiotics for a wide spectrum of symptoms and condi-
tions, anticipating that they would be an effective solu-
tion; credibility was conferred on those who dispensed 
them, which elevated the trustworthiness of community 
members who engaged in recommending and selling 
antibiotics, which in turn confirmed the reliability of the 
health information that they gave and justified further 
purchases.
Many people buy medicines there (…) so I trust that drug-
store, their medicines are good (…) like with my child for 
example, when she had a cold or a fever or something, she 
recovered after one or two doses (…) That medicine is ef-
fective right away. (25 years old, female, rural, Ca Mau)
Social responses to AMR
Most participants had some level of awareness about AMR 
due to health promotion campaigns that have occurred 
in recent years. However, very few of them were able to 
accurately explain the concept of antibiotic resistance. 
Despite their pervasive popularity, as previously noted, 
participants described actively rationing their use of anti-
biotics. This rationing was manifested by shortening the 
course. The rationale for this was that doing so would 
reduce the perceived risk of the individual in developing 
their own specific resistance, indicating community 
misperceptions about AMR.
It is said on TV that we should not abuse the antibiotic. (45 
years old, male, rural, Hanoi)
The residual effects of such campaigns appeared to be 
heightened sensitivity to the dangers of ‘too many anti-
biotics’ taken at a particular time, rather than under-
standing the need to target the use of antibiotics to 
bacterial infections and therefore the pertinence of accu-
rate diagnoses of conditions. Several participants directly 
referred to concerns about AMR when discussing their 
practices around using small amounts of antibiotics.
I heard from the TV that excess use of antibiotics will cause 
tolerance, but I take only a little, not much. I take it only 
once or twice every month or every two months. (51 years 
old, male, urban, Ca Mau)
The risks of AMR have been interpreted by many in the 
community as the risks of toxicity (from powerful, high- 
quality antibiotics) and the risk of the individual (ie, not 
specific microorganisms) becoming immune or tolerant 
to the therapeutic effects of antibiotics. The message that 
unnecessary antibiotic use may result in antibiotics not 
working in the future has been interpreted at the indi-
vidual level rather than being understood as a risk for the 
community as a whole.
My children are used to taking antibiotics. Cough drops 
and stuff like that don’t work anymore. (…) They can only 
use antibiotics now. (…) they don’t respond to mild medi-
cines anymore. (31 years old, female, rural, Hanoi)
DISCUSSION
This study provides insights into consumption practices 
of antibiotics within particular communities in Vietnam. 
Antibiotic use was frequent and driven by the powerful 
appeal that Western medicines generally, and antibi-
otics specifically, held for the vast majority of community 
participants. This appeal ran counter to, or at least inde-
pendent of, biomedical logic. Nonetheless, consumers 
demonstrated active discernment when making the 
decision to request and use antibiotics. Our sample was 
predominantly female for several reasons. Our initial 
findings pointed towards women being a particularly 
relevant group engaged in purchasing antibiotics, which 
pushed our sampling approach towards women. We also 
had some difficulty engaging men with the study topic, 
suggesting that decision- making about and purchasing of 
antibiotics is largely (although not exclusively) a female 
activity. While this was a multisite study, we did not find 
noteworthy differences between northern and southern 
regions, or urban and rural sites in terms of participants’ 
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practices or attitudes around antibiotics. Our findings 
highlight how individual behaviour is intrinsically both 
a response to, and a reflection of, structural conditions. 
Attention to these principles must inform the design of 
community interventions if progress is to be made in 
influencing the reduction unnecessary antibiotic use in 
Vietnam and elsewhere (see table 2 for key recommen-
dations). Additionally, it should be noted that a wide 
range of stakeholders, including clinicians, pharmacists 
and policymakers, should be consulted to inform such 
interventions. While this paper speaks to the community 
perspective, the perspectives of these groups have been 
captured through related studies under the larger V- RE-
SIST programme of work, and will be published sepa-
rately.
‘Inappropriate’ patient demand for antibiotics is often 
used to explain antibiotic overuse,25 and Vietnam is no 
exception. A previous study on antibiotic sales in Viet-
namese pharmacies declares that ‘overuse of antibiotics 
in the community is caused by people buying antibiotics 
after self- diagnosis or diagnosis by, often poorly trained, 
healthcare providers’13 but there has been very little 
consideration of the factors that drive people to buy anti-
biotics, and to self- medicate. Our findings demonstrate 
that, whether clinically indicated or not, antibiotics are 
highly valued, serving an important function in symptom 
management and the perceived attainment of ‘good 
health’. Our findings on the appeal of antibiotics within 
the community reflect this ‘quick fix’ as antibiotics offer 
a means to circumvent the need to navigate primary 
healthcare, saving patient- consumers’ time and money.34
Purchasing self- prescribed antibiotics is a mechanism to 
avoid participation in the formal healthcare system while 
accessing affordable, rapid care, with minimal impact on 
productivity. This reveals the shift towards the pharma-
ceuticalisation of care, where antimicrobial medicines 
are used as an alternative form of ‘healthcare’ in lieu of 
clinical attentiveness.25 Broom et al26 posit that universal 
access to healthcare would address the systemic causes of 
AMR, as it removes the pressure for ‘quick fix’ solutions, 
while also preventing health problems that may require 
antibiotics. Addressing AMR in the Vietnamese context 
is thus not simply about discouraging antibiotic use and 
enforcing regulatory legislation. Alternative pathways of 
healthcare must be offered. In Vietnam, this requires 
strengthening both the accessibility and the acceptability 
of the primary care model so that care, including appro-
priate (legal) prescribing, is available to all and engaging 
in it is made more appealing (table 2: KR2, KR6, KR7). 
We found that community members often preferred 
to use private pharmacies as a proxy for primary care 
because of the convenience, and the low opportunity 
costs compared with accessing primary care facilities. 
There are studies pointing towards patient dissatisfaction 
with primary care services in Vietnam, with complaints 
often centring around long waiting times, poor attitudes 
of staff and unsatisfactory facilities.35 While patients will 
often self- refer to higher level district and provincial 
services that they perceive to be of higher quality35 (even 
it means travelling further and spending more),36 for the 
minor ailments for which antibiotics are often sought, 
private pharmacies offer an attractive and convenient 
substitute for primary care. Our findings reflect that 
decision- making about purchasing antibiotics often falls 
to those in caring roles (ie, women). It is an important 
question, but was beyond the remit of this study, whether 
this gendered pattern persists into broader decision- 
making about whether or not to engage in the health-
care system beyond the initial purchase of antibiotics. If 
interventions are to encourage people to engage with 
the primary care system, a gendered approach to under-
standing the decision to engage with primary care would 
be constructive.
The knowledge deficit model of simply educating and 
raising awareness about AMR has been demonstrated to 
be problematic. This model typically does not engage 
with the non- biomedical and systemic drivers of health 
behaviours,25–27 37 and can have unforeseen consequences 
when information is translated through the prism of 
local knowledge. This is demonstrated by community 
Table 2 Key recommendations
Demand side interventions Supply side interventions
 ► Key recommendation (KR) 1: Engagement with community 
values and practices around antibiotics
 ► KR2: Increase awareness of existing direct pathways to 
primary healthcare and prescribers
 ► KR3: Investment in marketing appropriate alternatives to 
antibiotics, emphasising alternatives with qualities valued 
in antibiotics: efficacy, strength, affordability, accessibility 
(eg, paracetamol for fever and pain relief; oral rehydration 
salts for diarrhoea)
 ► KR4: Mass communication campaign engaging with 
influential figures and social networks at various levels 
(eg, national, regional, commune), involving community 
‘champions’ who are considered influential to promote key 
messages.
 ► KR5: Enforcement of regulatory legislation, including 
regulations requiring prescription- based dispensing and 
registration of pharmacies
 ► KR6: Implementation of health system reforms to improve 
affordability of primary care, aimed at reducing direct and 
indirect costs
 ► KR7: Incentivisation of improved access to qualified 
prescribers, for example, after- hours care in community- 
based primary healthcare centres
 ► KR8: Incentivisation of promotion of appropriate alternatives 
to antibiotics to relieve the symptoms of common illnesses
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members’ understanding of AMR, in which participants 
justified their decisions to cut short their course of medi-
cation based on their interpretation of how to mitigate the 
perceived risk of AMR. Stopping a course of antibiotics 
once symptoms subside is common practice throughout 
the world,10 38 and there is now evidence that suggests 
that directives to take the full course of antibiotics are 
ill- advised.39 Although cost has commonly been put 
forward as a foundational driver of prematurely ending a 
course of antibiotics, both in Vietnam and elsewhere,13 40 
our findings indicate that rather than being a cost- based 
decision, people have absorbed the message from Viet-
namese AMR awareness campaigns that by taking less 
than the full course they will be able to successfully and 
safely use antibiotics again next time they are ill.
Similarly, educating someone about the appropriate 
treatment for a viral versus a bacterial infection may not 
translate into reduced use of antibiotics if, to them, illness 
is defined by symptoms, and not a diagnosis. Drawing 
on Whyte et al’s concept of the symbolic nature of medi-
cines,41 illness is concretised by rendering the body 
economically unproductive. Antibiotics are thus valued 
for their symbolic association with enabling individuals 
to sustain their engagement in daily economic and rela-
tional productivity, making diagnosis at least temporarily 
irrelevant. Community interventions need to engage 
with these concepts in order to hope to be effective in 
reducing clinically unnecessary antibiotic use. Such an 
intervention needs to position an alternative treatment 
and/or behaviour that embodies similar values as anti-
biotics and serves similar perceived beneficial function 
(table 2: KR3, KR8). At the same time, interventions to 
reduce antibiotic use must consider the barriers inherent 
in the suggested alternative pathways if they are to be 
successful. One possible barrier is community opposition; 
the targeted reduction of antibiotic use can be perceived 
by community members as a denial of care, dismissal of 
their concerns and a lowering of the standard of care.42 43 
The prioritisation of symptom alleviation over a diagnosis 
may also be partly driven by the reportedly predominant 
communication style of health professionals in Vietnam. 
Previous research has found that health professionals do 
not often focus on eliciting detailed information from 
patients, and do not encourage patients to ask questions 
or display curiosity about their symptoms/condition.44 
The communication style typically favoured in formal, 
hierarchical interactions, such as that between a doctor 
and patient is often didactic and intended to be passively 
received by the patient.45
Community interventions to reduce antibiotic use 
should use the vehicle of the social production of trust 
to change the message about what constitutes appro-
priate antibiotic use and the promotion of alternatives. 
At the local level, the community endorses antibiotics 
as trusted medicines. Antibiotics are continually re- en-
dorsed through witnessed and embodied ‘evidence’ 
of their efficacy among community members. It is 
unclear whether there is a source of information that 
can compete with this social network endorsement. 
The public health establishment does not necessarily 
need to compete with social networks in this regard but 
engaging with how trust is produced is recommended, 
both for engaging the community in health promotion 
messages, and to foster trust in the health system. This is 
particularly pertinent in rural areas, where trusted health 
information was often conveyed by specific influential 
and respected community members during interactions 
that occurred in community hubs, which were better 
defined in rural communities compared with the more 
diffuse and diverse spaces for community interaction 
that are found in urban areas. For this reason, identifying 
and engaging ‘community champions’ to promote key 
messages around reducing antibiotic use could be partic-
ularly useful in rural communities (table 2: KR4).
Strengths and limitations
Strengths of this study include a heterogeneous sample, a 
rigorous data analysis process that drew on the multidisci-
plinary perspectives of the research team, and continual 
meaningful involvement of the local research team in all 
stages of the study. Limitations include that self- reported 
practice in interviews may differ from actual behaviour, 
and this may invite an element of social desirability bias. 
We attempted to minimise this by using a neutral inter-
viewer and assuring participants about confidentiality. 
While the sample for this study was heterogeneous and 
geographically diverse within Vietnam, due to the nature 
of the qualitative approach wider generalisability outside 
of Vietnam may be limited. However, by providing thor-
ough descriptions of the research contexts and methods, 
we have aimed to assist readers to determine the transfer-
ability of the findings to other contexts and participant 
groups, as is appropriate to the qualitative approach. 
This study limits the scope of the findings to antibiotic 
use in humans. We acknowledge that antibiotic use in 
food production (eg, preventive medication of livestock 
and over- the- counter availability of animal antibiotics) is 
an important part of the landscape of AMR in Vietnam 
that was not addressed in this study.
CONCLUSION
This study demonstrates that unnecessary antibiotic use 
at the community and primary care level in Vietnam is 
driven by a social and economic response to what consti-
tutes effective healthcare, rather than biomedical logic. 
These findings that engage with the socio- structural 
factors that drive unnecessary antibiotic use are to be 
operationalised in an intervention to be trialled, but 
they are also principles that need to be considered more 
broadly in the fight against AMR by focusing on the 
sociocultural and economic drivers of AMR alongside 
biomedical drivers. We have made recommendations 
that could target behaviour at the level of consumers, 
healthcare providers and drug sellers. These include 
increasing awareness of existing primary care pathways, 
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incentivising increased accessibility to prescribers, 
promoting alternatives to antibiotics that speak to the 
values that people prize in antibiotics and engaging with 
the social production of trust via influential community 
members. However, we recognise that this study also high-
lights additional structural changes that would need to 
accompany these individual behaviour changes at various 
levels in order to successfully combat AMR.
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